Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

My Size, Inc. (MYSZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9429-0.2571 (-21.43%)
At close: 04:00PM EDT
0.9871 +0.04 (+4.69%)
After hours: 06:56PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.2000
Open1.1600
Bid0.9110 x 800
Ask1.1000 x 1000
Day's Range0.8725 - 1.1899
52 Week Range0.8725 - 8.4750
Volume204,841
Avg. Volume178,092
Market Cap4.202M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-5.5300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MYSZ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • My Size, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    14 days agoMorningstar
View more
Advertisement
Advertisement